ALVERON PHARMA UK LTD

Active Grantham

Other research and experimental development on natural sciences and engineering

2 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineeringOther human health activities
A

ALVERON PHARMA UK LTD

Other research and experimental development on natural sciences and engineering

Founded 12 Mar 2019 Active Grantham, England 2 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineeringOther human health activities
Accounts Submitted 6 Feb 2026 Next due 30 Sept 2027 16 months remaining
Confirmation Submitted 14 Mar 2025 Next due 25 Mar 2026 2 months overdue
Net assets £5K £1M 2025 year on year
Total assets £5K £79K 2025 year on year
Total Liabilities £390 £2M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3 Castlegate Grantham Lincolnshire NG31 6SF England

Website

www.example.com

Full company profile for ALVERON PHARMA UK LTD (11877135), an active life sciences and medical technology company based in Grantham, England. Incorporated 12 Mar 2019. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2019–2025)

Cash in Bank

£1.30k

Decreased by £71.93k (-98%)

Net Assets

£4.59k

Increased by £1.43M (+100%)

Total Liabilities

£390.00

Decreased by £1.51M (-100%)

Turnover

N/A

Employees

2

Debt Ratio

8%

Decreased by 1789 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active
Status
Nichols, John Benjamin, DrDirectorBritishEngland6412 Mar 2019Active

Shareholders

Shareholders (1)

Alveron Pharma B.v.
100.0%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Alex Zwiers

Ceased 12 Mar 2020

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Mar 2026GazetteGazette Notice Voluntary
3 Mar 2026DissolutionDissolution Application Strike Off Company
6 Feb 2026AccountsAnnual accounts made up to 31 Dec 2025
14 Mar 2025Confirmation StatementConfirmation statement made on 11 Mar 2025 with no updates
10 Mar 2025AccountsAnnual accounts made up to 31 Dec 2024
10 Mar 2026 Gazette

Gazette Notice Voluntary

3 Mar 2026 Dissolution

Dissolution Application Strike Off Company

6 Feb 2026 Accounts

Annual accounts made up to 31 Dec 2025

14 Mar 2025 Confirmation Statement

Confirmation statement made on 11 Mar 2025 with no updates

10 Mar 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Gazette Notice Voluntary

2 months ago on 10 Mar 2026

Dissolution Application Strike Off Company

2 months ago on 3 Mar 2026

Annual accounts made up to 31 Dec 2025

3 months ago on 6 Feb 2026

Confirmation statement made on 11 Mar 2025 with no updates

1 years ago on 14 Mar 2025

Annual accounts made up to 31 Dec 2024

1 years ago on 10 Mar 2025